Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

NCT05298033 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: Crisaborole 2 % Topical Ointment
DRUG: PF-07038124 0.01% topical ointment
DEVICE: NBUVB phototherapy
DEVICE: Sham phototherapy
DRUG: Vehicle

Sponsor

University of Colorado, Denver

Collaborators

[object Object]